Innocan Pharma Corporation announced the filing of a joint application with Ramot at Tel Aviv University Ltd. (‘Ramot') to the World Intellectual Property Organization. The application pertains to the development of a novel platform for loading Cannabinoids on Exosomes. The collaboration between Innocan and Ramot (Tel Aviv University's technology transfer company), is aimed at creating a drug delivery platform that maximizes the activity of loaded Cannabinoids.

The new international patent application resulting from this joint effort is expected to expand the intellectual property space for cannabis-based products, opening exciting breakthrough opportunities. Innocan's portfolio of targeted healing products continues to expand, positioning the company as a leader in the field of cannabis- based therapeutics. With this new application, the company is well-positioned to unlock even greater potential for patients in need of effective treatment for chronic conditions.